Cromolyn Sodium

Uses

• Approved by the FDA in 1973 as the first prophylactic nonsteroidal drug available for treatment of chronic asthma.

• Alternative initial maintenance therapy for mild persistent and moderate persistent asthma.

• Preventative only; not effective during acute episodes of bronchospasm.

• Beneficial for allergic-component and exercise-induced asthma.

• May be beneficial in allergic rhinitis and atopic ocular diseases.

• Oral formulations for the management of mastocytosis, ulcerative colitis, and food allergies.

• Leukotriene receptor antagonists have largely replaced cromolyn sodium as the non-corticosteroid treatment of choice in the treatment of asthma.